Table 4

Prevalence and levels of antibodies to the OR domain of the P. falciparum P126 protein in Candeias do Jamari and Peixoto de Azevedo groups according to the infection patterns.

Infection

IgG

IgM

IgG1

IgG2

IgG3

IgG4


Candeias do Jamari (CJ)


OR-II

CJ-1993

47/69 (68)

4.9 ± 3.0d

39/63 (62)

3.4 ± 2.1

39/44a(88)

3.2 ± 2.1e

6/44b(13)

3.1 ± 2.9

42/44c(95)

10.6 ± 10.0

19/44 (43)

1.6 ± 0.7f

CJ-2002

55/70 (78)

8.4 ± 8.2j

57/70g (81)

4.8 ± 4.8

13/55h (23)

1.9 ± 0.7

19/55i(34)

1.3 ± 0.4

35/55 (60)

7.5 ± 6.1

23/55 (42)

2.6 ± 2.2k


Peixoto de Azevedo (PA)


OR-I

19/25 (76)

4.9 ± 2.9

13/25 (52)

1.7 ± 0.9

13/18l (72)

2.0 ± 1.8

0/18m

-

18/18n (100)

9.8 ± 6.8

9/18 (50)

1.4 ± 0.2

OR-II

36/46 (78)

4.3 ± 2.7

27/46 (59)

2.7 ± 1.7

21/36o (58)

2.1 ± 1.7

5/36p (14)

1.3 ± 0.4

34/36q (94)

7.6 ± 6.1

16/36 (44)

1.3 ± 0.1

Mixed

16/19 (84)

4.5 ± 3.1

9/19 (47)

2.0 ± 1.4

11/16r(69)

2.9 ± 2.7

0/16s

-

16/16 (100)t

7.5 ± 6.4

5/16 (31)

1.3 ± 0.1


The data represent the number of responders/total of each fragment tested (the percentage of responders is given in parentheses) and the antibody levels expressed as mean of OD index ± SD. P < 0.05. a: CJ-1993- IgG1 > IgG2, IgG1 > IgG4; CJ-1993 IgG1 > CJ-2002 IgG1; b: CJ-1993- IgG2 < IgG3, IgG2 < IgG4; CJ-1993 IgG2 < CJ-2002 IgG2; c: CJ-1993- IgG3 > IgG4; CJ-1993 IgG3 > CJ-2002 IgG3; d: CJ-1993 IgG < CJ-2002 IgG; e: CJ-1993 IgG1 > CJ-2002 IgG1; f: CJ-1993 IgG4 < CJ-2002 IgG4; g: CJ-2002 IgM > CJ-1993 IgM, CJ-2002 IgM > PA IgM; h: CJ-2002 IgG1 < IgG3; i: CJ-2002 IgG2 < IgG3; CJ-2002 IgG2 > PA OR-II IgG2; j: CJ-2002 IgG > PA OR-II IgG; k: CJ-2002 IgG4 > PA OR-II IgG4 l: PA OR-I IgG1 > IgG2; PA OR-I IgG1 < IgG3; m: PA OR-I IgG2 < IgG3; PA OR-I IgG2 < IgG4; n: PA OR-I IgG3 > IgG4; o: PA OR-II IgG1 > IgG2; PA OR-II IgG1 < IgG3; p: PA OR-II IgG2 < IgG3; PA OR-II IgG2 < IgG4; q: PA OR-II IgG3 > IgG4; CJ-2002 IgG3 < PA OR-II IgG3; r: PA mixed IgG1 > IgG2; s: PA mixed IgG2 > IgG3; t: PA mixed IgG3 > IgG4. The Student's t-test was used to analyse the differences in mean values, the Chi-square test was used to analyse the difference in prevalence of positive responses.

Pratt-Riccio et al. Malaria Journal 2008 7:144   doi:10.1186/1475-2875-7-144

Open Data